(Q37159577)

18 August 2017

1 reference

title

Empiric vs. preemptive antifungal treatment: an appraisal of treatment strategies in haematological patients (English)

1 reference

18 August 2017

Christina T Rieger

1

1 reference

18 August 2017

Helmut Ostermann

series ordinal

2

1 reference

18 August 2017

publication date

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

51 Suppl 1

1 reference

18 August 2017

page(s)

31-34

1 reference

Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2008.01526.X

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

21 January 2018

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

DOI

10.1111/J.1439-0507.2008.01526.X

1 reference

18 August 2017

1 reference